Intact Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,356
| Closed | -$660K | – | 274 |
|
|
2021
Q4 | $660K | Sell |
5,356
-2,678
| -33% | -$350K | 0.02% | 230 |
|
|
2021
Q3 | $1.14M | Buy |
8,034
+2,884
| +56% | +$424K | 0.03% | 188 |
|
|
2021
Q2 | $804K | Buy |
+5,150
| New | +$834K | 0.02% | 203 |
|
|
2020
Q4 | – | Sell |
-5,150
| Closed | -$680K | – | 258 |
|
|
2020
Q3 | $680K | Hold |
5,150
| – | – | 0.02% | 204 |
|
|
2020
Q2 | $597K | Buy |
5,150
+412
| +9% | +$47.5K | 0.02% | 208 |
|
|
2020
Q1 | $465K | Hold |
4,738
| – | – | 0.02% | 207 |
|
|
2019
Q4 | $688K | Buy |
4,738
+1,854
| +64% | +$256K | 0.02% | 208 |
|
|
2019
Q3 | $384K | Hold |
2,884
| – | – | 0.01% | 205 |
|
|
2019
Q2 | $329K | Hold |
2,884
| – | – | 0.01% | 216 |
|
|
2019
Q1 | $358K | Hold |
2,884
| – | – | 0.01% | 205 |
|
|
2018
Q4 | $290K | Sell |
2,884
-1,957
| -40% | -$220K | 0.01% | 202 |
|
|
2018
Q3 | $618K | Sell |
4,841
-103
| -2% | -$12.2K | 0.02% | 182 |
|
|
2018
Q2 | $535K | Buy |
4,944
+206
| +4% | +$22.4K | 0.02% | 178 |
|
|
2018
Q1 | $501K | Hold |
4,738
| – | – | 0.02% | 173 |
|
|
2017
Q4 | $555K | Hold |
4,738
| – | – | 0.02% | 150 |
|
|
2017
Q3 | $538K | Sell |
4,738
-1,339
| -22% | -$155K | 0.02% | 151 |
|
|
2017
Q2 | $757K | Hold |
6,077
| – | – | 0.03% | 138 |
|
|
2017
Q1 | $721K | Sell |
6,077
-3,296
| -35% | -$374K | 0.03% | 140 |
|
|
2016
Q4 | $939K | Buy |
9,373
+3,090
| +49% | +$331K | 0.03% | 156 |
|
|
2016
Q3 | $793K | Sell |
6,283
-721
| -10% | -$89.1K | 0.03% | 164 |
|
|
2016
Q2 | $818K | Hold |
7,004
| – | – | 0.03% | 163 |
|
|
2016
Q1 | $725K | Buy |
7,004
+824
| +13% | +$79.7K | 0.03% | 165 |
|
|
2015
Q4 | $615K | Hold |
6,180
| – | – | 0.03% | 170 |
|
|
2015
Q3 | $563K | Hold |
6,180
| – | – | 0.03% | 170 |
|
|
2015
Q2 | $654K | Hold |
6,180
| – | – | 0.03% | 172 |
|
|
2015
Q1 | $704K | Hold |
6,180
| – | – | 0.03% | 177 |
|
|
2014
Q4 | $680K | Hold |
6,180
| – | – | 0.03% | 178 |
|
|
2014
Q3 | $604K | Buy |
6,180
+721
| +13% | +$70.9K | 0.02% | 178 |
|
|
2014
Q2 | $550K | Hold |
5,459
| – | – | 0.02% | 172 |
|
|
2014
Q1 | $501K | Hold |
5,459
| – | – | 0.02% | 175 |
|
|
2013
Q4 | $494K | Hold |
5,459
| – | – | 0.02% | 154 |
|
|
2013
Q3 | $435K | Buy |
+5,459
| New | +$430K | 0.02% | 158 |
|
Other funds holding ZBH
Intact Investment Management's ZBH Position: Q1 2022 in Review
Intact Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 5,356 shares — an estimated $660K sold.
Intact Investment Management first reported a position in ZBH in Q3 2013 and held it in 32 quarters. The position peaked at $1.14M in Q3 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.
- Intact Investment Management reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
- Intact Investment Management sold 5,356 Zimmer Biomet shares in Q1 2022, an estimated $660K.
- Intact Investment Management first reported a position in Zimmer Biomet in Q3 2013 and held it in 32 quarters.
- Intact Investment Management's Zimmer Biomet position peaked at $1.14M in Q3 2021.
- 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.
Based on Intact Investment Management's 13F filing for Q1 2022, filed 16 May 2022.